IONIS PHARMACEUTICALS INC Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IONIS PHARMACEUTICALS INC for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 363 | 0 | 1,087 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 354 | 0 | 708 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 416 | 0 | 416 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 316 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 6,875 | 0 | 20,625 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 7,813 | 0 | 15,624 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 5,547 | 0 | 5,547 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 2,977 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 1,333 | 0 | 1,333 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 32,530 | 0 | 32,530 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 145 | 6,012 | 2,170 | 2.3 K to 2.2 K (-6.26 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 363 | 0 | 2,315 | 2 K to 2.3 K (+18.60 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 141 | 5,846 | 1,952 | 2.1 K to 2 K (-6.74 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 354 | 0 | 2,093 | 1.7 K to 2.1 K (+20.36 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 166 | 6,883 | 1,739 | 1.9 K to 1.7 K (-8.71 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 416 | 0 | 1,905 | 1.5 K to 1.9 K (+27.94 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 124 | 5,141 | 1,489 | 1.6 K to 1.5 K (-7.69 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 316 | 0 | 1,613 | 1.3 K to 1.6 K (+24.36 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.47 | 3,798 | 157,486 | 25,029 | 28.8 K to 25 K (-13.18 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 6,875 | 0 | 28,827 | 22 K to 28.8 K (+31.32 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 4,317 | 178,962 | 21,952 | 26.3 K to 22 K (-16.43 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 7,813 | 0 | 26,269 | 18.5 K to 26.3 K (+42.33 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 3,065 | 127,069 | 18,456 | 21.5 K to 18.5 K (-14.24 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 5,547 | 0 | 21,521 | 16 K to 21.5 K (+34.73 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.46 | 1,645 | 68,199 | 15,974 | 17.6 K to 16 K (-9.34 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 2,977 | 0 | 17,619 | 14.6 K to 17.6 K (+20.33 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 1,380 | 0 | 4,138 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 654 | 0 | 653 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 312 | 0 | 312 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 541 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | A | 0.00 | 6,373 | 0 | 6,373 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.47 | 550 | 22,806 | 6,331 | 6.9 K to 6.3 K (-7.99 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 1,380 | 0 | 6,881 | 5.5 K to 6.9 K (+25.09 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.47 | 747 | 30,975 | 5,501 | 6.2 K to 5.5 K (-11.96 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 1,875 | 0 | 6,248 | 4.4 K to 6.2 K (+42.88 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.46 | 261 | 10,822 | 4,373 | 4.6 K to 4.4 K (-5.63 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 654 | 0 | 4,634 | 4 K to 4.6 K (+16.43 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.46 | 125 | 5,182 | 3,980 | 4.1 K to 4 K (-3.05 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 312 | 0 | 4,105 | 3.8 K to 4.1 K (+8.23 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.47 | 216 | 8,957 | 3,793 | 4 K to 3.8 K (-5.39 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 541 | 0 | 4,009 | 3.5 K to 4 K (+15.60 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 1,311 | 0 | 3,931 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 654 | 0 | 653 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 312 | 0 | 312 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 541 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 0.00 | 6,373 | 0 | 6,373 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 41.46 | 522 | 21,641 | 9,124 | 9.6 K to 9.1 K (-5.41 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 1,311 | 0 | 9,646 | 8.3 K to 9.6 K (+15.73 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 41.47 | 747 | 30,975 | 8,335 | 9.1 K to 8.3 K (-8.23 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 1,875 | 0 | 9,082 | 7.2 K to 9.1 K (+26.02 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 41.46 | 261 | 10,821 | 7,207 | 7.5 K to 7.2 K (-3.49 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 654 | 0 | 7,468 | 6.8 K to 7.5 K (+9.60 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 41.46 | 125 | 5,182 | 6,814 | 6.9 K to 6.8 K (-1.80 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 312 | 0 | 6,939 | 6.6 K to 6.9 K (+4.71 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 41.46 | 216 | 8,955 | 6,627 | 6.8 K to 6.6 K (-3.16 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 541 | 0 | 6,843 | 6.3 K to 6.8 K (+8.58 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | M | 0.00 | 5,519 | 0 | 16,557 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | M | 0.00 | 3,438 | 0 | 6,874 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | M | 0.00 | 2,595 | 0 | 2,595 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | M | 0.00 | 1,715 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | A | 0.00 | 17,925 | 0 | 17,925 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Sell | S | 41.46 | 2,303 | 95,479 | 16,290 | 18.6 K to 16.3 K (-12.39 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Buy | M | 0.00 | 5,519 | 0 | 18,593 | 13.1 K to 18.6 K (+42.21 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Sell | S | 41.46 | 1,219 | 50,534 | 13,074 | 14.3 K to 13.1 K (-8.53 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Buy | M | 0.00 | 3,438 | 0 | 14,293 | 10.9 K to 14.3 K (+31.67 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Sell | S | 41.47 | 1,003 | 41,590 | 10,855 | 11.9 K to 10.9 K (-8.46 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Buy | M | 0.00 | 2,595 | 0 | 11,858 | 9.3 K to 11.9 K (+28.01 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Sell | S | 41.46 | 667 | 27,653 | 9,263 | 9.9 K to 9.3 K (-6.72 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Buy | M | 0.00 | 1,715 | 0 | 9,930 | 8.2 K to 9.9 K (+20.88 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 1,380 | 0 | 4,138 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 1,397 | 0 | 1,397 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 775 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 0.00 | 6,373 | 0 | 6,373 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 41.46 | 550 | 22,802 | 8,354 | 8.9 K to 8.4 K (-6.18 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 1,380 | 0 | 8,904 | 7.5 K to 8.9 K (+18.34 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 41.46 | 747 | 30,967 | 7,524 | 8.3 K to 7.5 K (-9.03 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 1,875 | 0 | 8,271 | 6.4 K to 8.3 K (+29.32 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 41.47 | 556 | 23,056 | 6,396 | 7 K to 6.4 K (-8.00 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 1,397 | 0 | 6,952 | 5.6 K to 7 K (+25.15 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 41.46 | 309 | 12,810 | 5,555 | 5.9 K to 5.6 K (-5.27 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 775 | 0 | 5,864 | 5.1 K to 5.9 K (+15.23 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,518 | 0 | 4,552 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,415 | 0 | 1,415 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 208 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 527 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | A | 0.00 | 6,373 | 0 | 6,373 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 41.46 | 604 | 25,041 | 7,693 | 8.3 K to 7.7 K (-7.28 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,518 | 0 | 8,297 | 6.8 K to 8.3 K (+22.39 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 41.46 | 747 | 30,969 | 6,779 | 7.5 K to 6.8 K (-9.93 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,875 | 0 | 7,526 | 5.7 K to 7.5 K (+33.18 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 41.46 | 564 | 23,382 | 5,651 | 6.2 K to 5.7 K (-9.07 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,415 | 0 | 6,215 | 4.8 K to 6.2 K (+29.48 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 41.47 | 83 | 3,442 | 4,800 | 4.9 K to 4.8 K (-1.70 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 208 | 0 | 4,883 | 4.7 K to 4.9 K (+4.45 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 41.46 | 210 | 8,707 | 4,675 | 4.9 K to 4.7 K (-4.30 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 527 | 0 | 4,885 | 4.4 K to 4.9 K (+12.09 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,188 | 0 | 6,562 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 5,178 | 0 | 5,178 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 41.46 | 872 | 36,151 | 1,735 | 2.6 K to 1.7 K (-33.45 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 2,188 | 0 | 2,607 | 419 to 2.6 K (+522.20 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 0.00 | 1,311 | 0 | 3,931 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 0.00 | 1,415 | 0 | 1,415 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 0.00 | 694 | 0 | 0 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | A | 0.00 | 6,373 | 0 | 6,373 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 41.46 | 522 | 21,640 | 10,590 | 11.1 K to 10.6 K (-4.70 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 0.00 | 1,311 | 0 | 11,112 | 9.8 K to 11.1 K (+13.38 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 41.46 | 747 | 30,967 | 9,801 | 10.5 K to 9.8 K (-7.08 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 0.00 | 1,875 | 0 | 10,548 | 8.7 K to 10.5 K (+21.62 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 41.46 | 564 | 23,383 | 8,673 | 9.2 K to 8.7 K (-6.11 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 0.00 | 1,415 | 0 | 9,237 | 7.8 K to 9.2 K (+18.09 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 41.46 | 277 | 11,484 | 7,822 | 8.1 K to 7.8 K (-3.42 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 0.00 | 694 | 0 | 8,099 | 7.4 K to 8.1 K (+9.37 %) |
| Jan 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 9.22 | 500 | 4,610 | 500 | |
| Jan 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 5,000 | 51,450 | 86,259 | |
| Jan 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 62.10 | 500 | 31,050 | 1,297 | 1.8 K to 1.3 K (-27.82 %) |
| Jan 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 9.22 | 500 | 4,610 | 1,797 | 1.3 K to 1.8 K (+38.55 %) |
| Jan 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 62.10 | 5,000 | 310,500 | 14,642 | 19.6 K to 14.6 K (-25.46 %) |
| Jan 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 5,000 | 51,450 | 19,642 | 14.6 K to 19.6 K (+34.15 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | M | 14.69 | 809 | 11,884 | 28,545 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Option Exercise | A | 61.68 | 107,549 | 6,633,622 | 107,549 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Sell | S | 61.05 | 809 | 49,389 | 8,215 | 9 K to 8.2 K (-8.96 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Buy | M | 14.69 | 809 | 11,884 | 9,024 | 8.2 K to 9 K (+9.85 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO & Secretary | Buy | J | 47.71 | 72 | 3,435 | 8,215 | 8.1 K to 8.2 K (+0.88 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 7.25 | 848 | 6,148 | 1,219 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 152 | 1,645 | 7,101 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 61.68 | 38,240 | 2,358,643 | 38,240 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 61.10 | 848 | 51,813 | 6,302 | 7.2 K to 6.3 K (-11.86 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 7.25 | 848 | 6,148 | 7,150 | 6.3 K to 7.2 K (+13.46 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 61.10 | 152 | 9,287 | 6,302 | 6.5 K to 6.3 K (-2.36 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 152 | 1,645 | 6,454 | 6.3 K to 6.5 K (+2.41 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | J | 47.71 | 43 | 2,052 | 6,302 | 6.3 K to 6.3 K (+0.69 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | A | 61.68 | 38,240 | 2,358,643 | 38,240 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 61.00 | 127 | 7,747 | 4,358 | 4.5 K to 4.4 K (-2.83 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | J | 47.71 | 130 | 6,202 | 4,485 | 4.4 K to 4.5 K (+2.99 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | A | 61.68 | 38,240 | 2,358,643 | 38,240 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | J | 47.71 | 41 | 1,956 | 3,468 | 3.4 K to 3.5 K (+1.20 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 61.68 | 38,240 | 2,358,643 | 38,240 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 47.71 | 269 | 12,834 | 5,089 | 4.8 K to 5.1 K (+5.58 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 9.22 | 1,000 | 9,220 | 1,000 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 10,000 | 102,900 | 91,259 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 61.68 | 8,000 | 493,440 | 8,000 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 61.68 | 195,182 | 12,038,826 | 195,182 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 61.05 | 1,000 | 61,050 | 1,297 | 2.3 K to 1.3 K (-43.54 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 9.22 | 1,000 | 9,220 | 2,297 | 1.3 K to 2.3 K (+77.10 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 61.05 | 10,000 | 610,500 | 14,642 | 24.6 K to 14.6 K (-40.58 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 10,000 | 102,900 | 24,642 | 14.6 K to 24.6 K (+68.30 %) |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 61.68 | 31,070 | 1,916,398 | 31,070 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 47.71 | 419 | 19,991 | 419 | 0 to 419 |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | A | 61.68 | 38,240 | 2,358,643 | 38,240 | |
| Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 47.71 | 89 | 4,246 | 7,405 | 7.3 K to 7.4 K (+1.22 %) |